Ambagon Therapeutics
Alan Ashworth, Ph.D., FRS, is President of the UCSF Helen Diller Family Comprehensive Cancer Center, and Senior Vice President for Cancer Services with UCSF Health. Prior to joining UCSF, he served as Chief Executive of the Institute of Cancer Research (ICR) and the Director of the Breakthrough Breast Cancer Research Centre in London, United Kingdom. A translational biologist and laboratory researcher, Ashworth’s research focuses on understanding cancer genetics and genomes to improve the treatment and care of patients.
This person is not in the org chart
This person is not in any offices
Ambagon Therapeutics
Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.